Hemenway Trust Hemenway Trust’s Epizyme, Inc EPZM Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-18,000	Closed	-$432K	–	225
2015 Q2	$432K	Hold	18,000	–	–	0.11%	114
2015 Q1	$338K	Hold	18,000	–	–	0.09%	126
2014 Q4	$340K	Hold	18,000	–	–	0.1%	103
2014 Q3	$488K	Sell	18,000 -13,000	-42%	-$404K	0.15%	83
2014 Q2	$965K	Sell	31,000 -9,000	-23%	-$212K	0.29%	63
2014 Q1	$911K	Sell	40,000 -26,666	-40%	-$808K	0.29%	61
2013 Q4	$1.39M	Buy	+66,666	New	+$1.93M	0.44%	55

Other funds holding EPZM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Hemenway Trust Hemenway Trust's EPZM Position: Q3 2015 in Review

Hemenway Trust Hemenway Trust sold out of Epizyme, Inc (EPZM) in Q3 2015, closing a stake of 18,000 shares — an estimated $432K sold.

Hemenway Trust Hemenway Trust first reported a position in EPZM in Q4 2013 and held it in 7 quarters. The position peaked at $1.39M in Q4 2013. 98 funds tracked by Wall St. Rank hold EPZM as of Q3 2015.

Hemenway Trust Hemenway Trust reported no remaining Epizyme, Inc position as of Q3 2015 after selling out during the quarter.
Hemenway Trust Hemenway Trust sold 18,000 Epizyme, Inc shares in Q3 2015, an estimated $432K.
Hemenway Trust Hemenway Trust first reported a position in Epizyme, Inc in Q4 2013 and held it in 7 quarters.
Hemenway Trust Hemenway Trust's Epizyme, Inc position peaked at $1.39M in Q4 2013.
98 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2015.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q3 2015, filed 13 Nov 2015.